Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
05/2012
05/02/2012EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/02/2012EP1399133B2 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same
05/02/2012CN102432634A 2-amino-4-(2'-pyridine)-pyrimidine-2-peroxo vanadium ammonium salt complex, method for cultivating single crystal of 2-amino-4-(2'-pyridine)-pyrimidine-2-peroxo vanadium ammonium salt complex, and application of 2-amino-4-(2'-pyridine)-pyrimidine-2-peroxo vanadium ammonium salt complex
05/02/2012CN102432599A Crystal form of oxalate of dipeptidyl peptidase inhibitor and preparation method and application thereof
05/02/2012CN102430038A Composition for improving blood testosterone, and composition-containing preparation and preparation method thereof
05/02/2012CN102430028A Chinese medicinal patch for treating polycystic ovary syndrome and preparation method thereof
05/02/2012CN101558870B Mulberry and sea backthern concentrated food
05/02/2012CN101065363B Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
05/01/2012US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
05/01/2012US8168619 Hormonal composition based on a progestational agent and an oestrogen and use thereof
05/01/2012US8168616 Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
05/01/2012US8168189 Protein A compositions and methods of use
05/01/2012CA2473566C Pim-3 kinase as a target for type 2 diabetes mellitus
05/01/2012CA2437579C Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
04/2012
04/26/2012WO2012053630A1 Antagonist for mutated androgen receptor
04/26/2012WO2012053003A1 A novel herbal oil for controlling blood sugar without risk of hypoglycemea
04/26/2012US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
04/26/2012US20120101105 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
04/26/2012US20120101039 Calcium-sensing receptor-active compounds
04/26/2012US20120100235 Papaya puree and uses thereof
04/26/2012US20120100115 Regionalised endoderm cells and uses thereof
04/26/2012US20120100071 Synthesis and use of radiolabelled insulin analogues
04/26/2012CA2813063A1 Antagonist for mutated androgen receptor
04/25/2012EP2443134A2 NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF
04/25/2012CN101284795B 一类非甾体雄激素受体调节剂及其医学用途 A class of non-steroidal androgen receptor modulators and their medical uses
04/24/2012US8163957 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
04/24/2012US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
04/24/2012US8163722 Pharmaceutical formulation for contraception and hormone-replacement therapy
04/24/2012CA2506290C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
04/24/2012CA2433807C Hydrophobic polyamine analogs and methods for their use
04/19/2012WO2012048446A1 New use of chemical ingredients in cynomorium as phytoestrogen
04/19/2012US20120095081 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
04/19/2012US20120095063 Methods and compositions for treatment of ischemic conditions and conditions related to mitochondrial function
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120094966 Organic compounds
04/19/2012US20120093914 Implantable liposome embedded matrix composition, uses thereof, and polycaprolactone particles as scaffolds for tissue regeneration
04/18/2012EP2441456A1 DHEA compositions for treating menopose
04/18/2012EP2441450A1 Antioxidant composition for reducing the oxidative stress and side effects ascribable to treatment with levothyroxine
04/18/2012EP2441443A1 Lactoferrin based complex coacervates and their uses
04/18/2012EP2440567A1 Substituted 16,17-annellated steroid compounds for use in women's healthcare
04/18/2012EP1284724B1 Method of preparing alkylated salicylamides via a dicarboxylate intermediate
04/18/2012CN102421773A Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/18/2012CN102416102A Refreshing and brain-invigorating tea
04/18/2012CN102416001A 一种注射用醋酸奥曲肽冻干粉针剂及其制备方法 An injection of octreotide acetate freeze-dried powder and its preparation method
04/18/2012CN101647840B 用于控制代谢症候群的中草药组成物及其制备方法 Control of metabolic syndrome herbal composition and preparation methods for
04/18/2012CN101394841B 快速起作用的口服肽药品 Fast-acting oral peptide drug
04/12/2012WO2012048099A2 Nanoparticle-loaded cells
04/12/2012WO2012048093A2 Enhanced msc preparations
04/12/2012WO2012046869A1 Cyclic amide derivative
04/12/2012WO2012045801A1 Lactoferrin based complex coacervates and their uses
04/12/2012US20120088839 Composition for regulating cellular senescence comprising [n-2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide
04/12/2012US20120088825 Compounds with activity at estrogen receptors
04/12/2012US20120088725 5-cnac as oral delivery agent for parathyroid hormone fragments
04/12/2012US20120088724 Human Growth Hormone Formulations
04/12/2012US20120087933 Enhanced msc preparations
04/12/2012CA2813639A1 Cyclic amide derivative
04/11/2012EP2062883B1 Catechin as insulin sensitivity improving agent
04/11/2012EP1320387B1 Pharmaceutical compositions for sustained delivery of peptides
04/11/2012CN102414180A 作为沉默调节蛋白调节剂的8-取代的喹啉及相关的类似物 As a sirtuin modulators 8-substituted quinoline and related analogs
04/11/2012CN102413828A 作为食欲素受体拮抗剂的噻唑烷-4-酮和[1,3]-噻嗪烷-4-酮化合物 Orexin receptor antagonists as thiazolidine-4-one and [1,3] - thiazine-4-one compound of
04/11/2012CN102408429A Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
04/11/2012CN102406821A Traditional Chinese medicine for treating simple goiter
04/11/2012CN102406693A 一种双水相体系富集分离红车轴草异黄酮类物质的方法 A two-phase system of water enrichment and separation of red clover isoflavones methods
04/11/2012CN102406650A 单独的性甾体前体或与选择性雌激素受体调节剂联合用于防治绝经后女性的阴道疾病和病症 Separate sex steroid precursor or selective estrogen receptor modulators for the combined prevention and treatment of postmenopausal women with vaginal diseases and disorders
04/11/2012CN102406630A 包被的药物递送制剂 Drug delivery formulations coated
04/11/2012CN102406605A 雄性激素类药物的醇质体制剂及其制备方法 Alcohol oleosome its preparation method androgen drugs
04/10/2012US8153806 Synthesis of 4-amino-thalidomide enantiomers
04/10/2012US8153587 Orally administering parathyroid hormone and calcitonin
04/10/2012US8153117 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas
04/10/2012CA2534349C Human skin equivalents expressing exogenous polypeptides
04/10/2012CA2352573C Glp-1 analogues
04/05/2012WO2012043505A1 Novel piperidine derivative and pharmaceutical containing same
04/05/2012WO2011146109A3 Methods and assays for treating subjects with shank3 deletion, mutation or reduced expression
04/05/2012US20120083494 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
04/05/2012US20120083492 Imidazopyrazines for use as kinase inhibitors
04/05/2012US20120083480 Controlled release delivery system for nasal applications
04/05/2012US20120082724 Dry mouldable drug formulation
04/05/2012US20120082717 Complex, multilayer using the same, and device coated with the multilayer
04/05/2012US20120082635 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
04/04/2012EP2436381A1 Crystallization of hydrohalides of pharmaceutical compounds
04/04/2012EP2435462A1 Novel glucocorticoid receptor agonists
04/04/2012EP2097420B1 Spiroketone inhibitors of acetyl-coa carboxylase
04/04/2012EP1911743B1 Cyclic amine compound
04/04/2012CN102399741A Culture solution and method for producing hemopoietic stem cell by reversely splitting somatic cell and application of culture liquid
04/04/2012CN102399740A Method and kit allowing reverse differentiation of human somatic cells for generation of autologous pancreatic stem cells and autologous pancreas islet, and application thereof
04/04/2012CN102397499A 一种治疗垂体前叶机能减退症的中药药方的制备方法 Preparation method of treating hypothyroidism anterior pituitary function of traditional Chinese medicine prescription
04/04/2012CN102397465A Traditional Chinese medicine for treating nanism, activating self growth potential, invigorating brain and increasing intelligence
04/04/2012CN102397275A 芳香化酶抑制剂 Aromatase inhibitors
04/04/2012CN102397255A Progesterone ethosome, and preparation method and application thereof
04/03/2012US8148429 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
03/2012
03/29/2012WO2012040364A1 Calcitonin products and therapies for treating inflammatory or degenerative diseases
03/29/2012US20120077845 Estrogen receptor ligands and methods of use thereof
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077808 Niacin Mimetics, and Methods of Use Thereof
03/29/2012US20120077807 Niacin mimetics, and methods of use thereof
03/29/2012US20120077790 Ulipristal Acetate Tablets
03/29/2012US20120077787 Organic compounds
03/29/2012US20120077775 Macrocyclic compounds useful as inhibitors of kinases and hsp90
03/29/2012US20120077732 Cyclic peptides and uses thereof
03/29/2012US20120076855 Oral testosterone composition
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 290